Exeter Science News Today

The (Devon) cream rises to the top

The 142-room hotel is set to open next year and will be IHG’s “first lifecycle net zero carbon hotel”…

Red Construction South West has broken ground for a new £22m hotel in Exeter.

The partnership with the regional hubs will see the SETsquared Exeter team having a presence in the partner facilities in order to meet with start-up

LONDON: Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India, a new UK government study has reportedly found. The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus. The UK findings are said to be based on data fro...

Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.

1354 People wearing protective face masks wait to receive their second dose of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, outside a vaccination centre in Kolkata on May 12, 2021. Reuters file photo London, May 22 Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly foun...

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus

A new UK government study shows that two doses of either the AstraZeneca or Pfizer Covid vaccine provide more than 80 per cent protection against the variant first found in India.